AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC). Top-line results from the ...
MIT and IBM released ChartNet, a 1.7-million-sample synthetic training dataset that lets compact open-source vision-language ...
Michael Logan is an experienced writer, producer, and editorial leader. As a journalist, he has extensively covered business and tech news in the U.S. and Asia. He has produced multimedia content that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results